PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
27-Feb-2024 PureTech to Present at Two Upcoming Investor Conferences PureTech Health
27-Feb-2024 Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Community Mainz BioMed N.V.
27-Feb-2024 Straumann Group grew 9.8 percent organically in 2023 while investing in future growth Straumann Holding AG
26-Feb-2024 International working group in pharmacovigilance launches new studies into causal inference and data sources Drug Safety Research Unit
23-Feb-2024 Cannovum Cannabis AG: Bundestag approves legalization of cannabis in Germany, historic opportunity for the economy, billion-euro potential for sales and growth Cannovum Cannabis AG
23-Feb-2024 MEDICLIN: Contract for the sale of the MEDICLIN Herzzentrum Coswig has been signed MediClin AG
23-Feb-2024 Modern Dental Group: Advocates of digital dentistry from the lab Modern Dental Group Limited
22-Feb-2024 New Pistoia Alliance Survey Reveals Only 9% Of Life Science Professionals Understand Laws Regulating AI in US and EU The Pistoia Alliance
22-Feb-2024 STORM Therapeutics to Present Findings on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at ESMO Targeted Anticancer Therapies Congress STORM Therapeutics Ltd
22-Feb-2024 UKHSA announced as first PACE collaboration to help tackle deadly antimicrobial resistance PACE
22-Feb-2024 Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert® Mainz BioMed N.V.
22-Feb-2024 Gerresheimer decisively continues on profitable growth course in financial year 2023 Gerresheimer AG
21-Feb-2024 Polpharma Biologics’ investigational biosimilar shows PK/PD comparability to inflammatory bowel disease blockbuster Entyvio®* Polpharma
21-Feb-2024 Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italy Mainz BioMed N.V.
21-Feb-2024 Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program Mestag Therapeutics
21-Feb-2024 Conference call on the results for the 1st quarter 2023/24 (ending 31 December 2023) on 22 February 2024 Douglas GmbH
20-Feb-2024 Principal IRB Becomes Univo IRB With Support From QHP Capital Univo IRB
20-Feb-2024 Omnix Medical Granted Fast-Track Designation by U.S. FDA for its Next-Generation Anti-Infective OMN6 Omnix Medical
19-Feb-2024 Bayer Aktiengesellschaft: Bayer plans to amend its dividend policy to reduce debt Bayer Aktiengesellschaft
19-Feb-2024 Envirotainer commits to ambitious science-based targets to cut down supply chain emissions Envirotainer